Ketorolac for Post-Tonsillectomy Pain in Children

"To join this medical trial, applicants must suffer from adenotonsillar hypertrophy and be aged between 3 to 12 years old. The targeted recruitment is 200 participants in total."

"Indeed. Clinicaltrials.gov's records demonstrate that this research project, which was initially uploaded on February 8th 2022, is actively recruiting participants. The study hopes to enroll 200 people from a single medical facility."

"Ketorolac is commonly prescribed for treating ocular itching but can also serve as a remedy for pain, pupil dilation, and induction of nerve block."

"This trial requires participants aged between 3 and 12. For those under 18, there are 126 studies available, while 691 trials exist for patients over 65."

"This is accurate. Clinicaltrials.gov displays that 200 patients are being sought for this medical trial, which was first posted on February 8th 2022 and recently updated on February 20th 2022. One single location will be administering the study to participants."

"The safety profile of Ketorolac has been well established in a Phase 4 trial, resulting in its assessment on the Power team's scale being rated as 3."

"At the moment, 38 medical trials are evaluating Ketorolac's effectiveness. Of those studies, 8 have reached Phase 3 status. The majority of these tests occur in Los Angeles; however, 57 other sites from across the US have begun to conduct their own investigations."